CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial. - Lazaar, Aili L.; Miller, Bruce E.; Donald, Alison C.; Keeley, Thomas; Ambery, Claire; Russell, John; Watz, Henrik; Tal-Singer, Ruth; for 205724 Investigators; Bardin, Philip; Bremner, Peter; Langton, David; et al. (Respiratory Research, 2020)